Shedding light on the link between a type of antibodies and miscarriage
Miscarriage affects an estimated 15% of pregnancies, but in about half of cases the cause is unclear. At Yale, reproductive immunologist Vikki Abrahams and reproductive biologist Mancy Tong are interested in shedding light on one of these causes.Source: YaleNews
WHRY Launches Studies on Endometrial Cancer, Addiction to Opioids, and Stroke
While continuing to focus on the impacts of COVID-19, the center has enlarged its research portfolio to include new projects on the prevention of endometrial cancer in a growing cohort of women at high risk, non-opioid pain management following a cesarean section for women with opioid use disorder who are in recovery, and sex differences in stroke.
WHRY Funds Studies on Stroke, Endometrial Cancer, and Addiction to Opioids
Women’s Health Research at Yale today announced funding for three studies investigating sex differences in stroke, endometrial cancer, and alternate pain relief for women recovering from past opioid use who are giving birth via cesarean section.
Taylor Receives the “Distinguished Scientist Award” from Society for Reproductive Investigation for 2020
The 2020 Society for Reproductive Investigation “Distinguished Scientist Award” is given to Hugh S. Taylor, MD, chair of the Department of Obstetrics, Gynecology and Reproductive Sciences at Yale.
The Important Work of Dr. Harvey Kliman and Why His Research Matters in 2022
Today we welcome Dr. Harvey Kliman to the podcast. He graciously spends time with us diving into why his research is important to those who have experienced infertility, or pregnancy and infant loss, why it's not often not prioritized in the world of research and what he feels like are large barriers in our healthcare system today. Thank you to Dr. Kliman for coming to the podcast to share the data, science and research that gives loss families information, and at times, closure, when they otherwise had none. We are so thankful for your work in the world, Dr. Kliman. If you have experienced pregnancy or infant loss and would like to contact Dr. Kliman and his team to investigate your case further, you can find more information here: https://medicine.yale.edu/obgyn/kliman/placenta/pregnancyloss/Source: Ripples Through Waves
Building Momentum: WHRY's Undergraduate Fellows Advance Women's Health
Women’s Health Research at Yale mentors undergraduate students as well as graduate students and rising junior faculty members to ensure that the next generation of scientists and medical providers fully account for the health needs of women and sex-and-gender differences affecting health. Here are a few examples of what our former undergraduate fellows are up to now.
Yale Physicians Share the Symptoms of Ovarian Cancer
September is ovarian cancer awareness month and while ovarian cancer is rare, the survival rate is low. Ovarian cancer is not easily detectable in its early stages. According to the American Cancer Society, the most common symptoms include bloating, pelvic-abdominal pain, and urinary symptoms. News 8 spoke with co-directors of the Sexual Intimacy and Menopause Program at Smilow Cancer Hospital in New Haven.Source: WTNH
Ideal gestational weight gain varies by pre-pregnancy BMI in twin pregnancy
For people giving birth to twins, the gestational weight gain range with the lowest risk for adverse perinatal outcomes was similar among those with a pre-pregnancy BMI of underweight or normal weight. However, the ideal range for gestational weight gain (GWG) for twin pregnancy decreased with each successively higher BMI category, data in JAMA Network Open showed. The data suggest that the current United States Institute of Medicine GWG recommendations should be lower.Source: Healio
Using Particles That Are Smaller Than the Head of a Pin to Treat Cancer
Thanks in part to research begun more than a decade ago with funding from Women’s Health Research at Yale, Dr. W. Mark Saltzman is working with colleagues on a way to deploy effective cancer-fighting medication safely with the help of nanoparticles.
Yale Gynecologic Pathologists Are Pioneers in Clinical Validation and Application of Molecular Genotyping for Gestational Trophoblastic Disease
Yale Pathology’s experienced gynecological pathologists are pioneers in the clinical validation and application of molecular genotyping for gestational trophoblastic disease (GTD).
Breaking the Egg Barrier: A Sperm Story
Yale Physiology researchers found that sperm hyperactivation is an evolutionary conserved mechanism to penetrate the egg barriers, used as early as in monotreme but diverged to use it as a way of navigation in the female reproductive tract when it become more complicated in placenta mammals.